Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

NCT06431789 is registered in ClinicalTrials.gov with Yi Han as lead sponsor.

NCT NCT06431789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06431789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency
Lead sponsor
Yi Han
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2024
Completion date
April 30, 2026
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

edoxaban, gene polymorphism, renal insufficiency